|
Re: ZHCLF
|
2
|
Zenith Epigenetics
|
Jul 22, 2022 02:40PM
|
|
Re: ZHCLF
|
4
|
Zenith Epigenetics
|
Feb 06, 2024 11:23AM
|
|
Re: ZHCLF
|
4
|
Zenith Epigenetics
|
Jan 30, 2024 04:37PM
|
|
Re: zenith trials
|
1
|
Zenith Epigenetics
|
Dec 10, 2022 01:40PM
|
|
Re: Zenith trial partners
|
4
|
Zenith Epigenetics
|
Jan 29, 2023 03:42PM
|
|
Re: Zenith share issue
|
6
|
Zenith Epigenetics
|
Nov 14, 2017 01:11PM
|
|
Re: Zenith share issue
|
6
|
Zenith Epigenetics
|
Nov 15, 2017 12:39PM
|
|
Re: Zenith share issue
|
6
|
Zenith Epigenetics
|
Nov 15, 2017 03:30PM
|
|
Re: Zenith Q4 2017 Events
|
3
|
Zenith Epigenetics
|
Nov 13, 2017 12:49PM
|
|
Re: Zenith Private placement??
|
3
|
Zenith Epigenetics
|
Jul 11, 2018 11:33AM
|
|
Re: Zenith Private placement??
|
5
|
Zenith Epigenetics
|
Feb 21, 2018 10:26AM
|
|
Re: Zenith News
|
3
|
Zenith Epigenetics
|
May 04, 2020 05:46PM
|
|
Re: Zenith new VP
|
3
|
Zenith Epigenetics
|
Jul 30, 2017 12:44PM
|
|
Re: Zenith new VP
|
1
|
Zenith Epigenetics
|
Aug 01, 2017 12:57PM
|
|
Re: Zenith funding???
|
4
|
Zenith Epigenetics
|
Jun 25, 2019 10:59AM
|
|
Re: Zenith Epigentics and Resverlogix update 22 Jan 2018
|
6
|
Zenith Epigenetics
|
Feb 01, 2018 12:14PM
|
|
Re: Zenith Epigenetics Triple Negative Breast Cancer Clinical Data Highlighted in an Oral Discussion at the ASCO Conference
|
5
|
Zenith Epigenetics
|
Jun 21, 2022 09:16AM
|
|
Re: Zenith Epigenetics Triple Negative Breast Cancer Clinical Data Highlighted in an Oral Discussion at the ASCO Conference
|
4
|
Zenith Epigenetics
|
Jun 22, 2022 10:40AM
|
|
Re: Zenith Epigenetics Receives US$5 Million Milestone Payment from Newsoara
|
4
|
Zenith Epigenetics
|
Feb 02, 2020 09:48AM
|
|
Re: Zenith Epigenetics Proudly Supports Rare Disease Day ZEN-3694 Expands Development to Include Multiple Rare Oncology Indications Calgary, Alberta--(N
|
7
|
Zenith Epigenetics
|
Mar 01, 2024 12:47PM
|
